E
Nuvectis Pharma, Inc. NVCT
$9.44 -$0.05-0.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -6.25M -4.15M -4.43M -4.17M -6.62M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.14M 1.16M 1.26M 1.30M 1.22M
Change in Net Operating Assets 2.64M 590.00K 146.00K -1.48M 1.55M
Cash from Operations -2.47M -2.40M -3.02M -4.36M -3.85M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3.95M 1.51M 1.73M 4.85M 901.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -124.00K -50.00K -55.00K -153.00K 16.00K
Cash from Financing 3.83M 1.46M 1.67M 4.70M 917.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.36M -947.00K -1.35M 338.00K -2.93M
Weiss Ratings